Toronto Ottawa Heart Summit - Heart Failure Update


Abstract Submission Guidelines (2024)


  • Call for Abstract Opens: April 18, 2024
  • Deadline for Submission: May 10, 2024
  • Notification to Applicants: May 30, 2024

The Toronto-Ottawa Heart Summit will take place on June 14-15, 2024 at the National Arts Centre.

The 26th Toronto-Ottawa Heart Summit promises to bring together national and international experts and stakeholders to provide the latest discoveries and innovations in cardiovascular health and professional interactions that help to define the current frontiers in cardiovascular science.

This accredited event will bring together translational scientists, clinician scientists, cardiologists and trainees in cardiovascular science, and will facilitate scientific dialogue, exchange of information, and networking that will enable international collaborative opportunities. Additional sessions outside of plenary lectures will include a trainee career networking event.

The Scientific Review Committee for this combined program is now seeking abstracts of original research for Poster and Rapid-Fire Oral Presentations. Please read this guideline carefully before completing the online submission form, which can be found here.


Eligibility Requirements for Submission of Abstracts:

  • Fellows enrolled in a clinical training program
  • Residents enrolled in a clinical training program
  • Medical students
  • Postdoctoral fellows
  • Graduate students
  • Undergraduate students


  • Abstract submissions portal:
  • If you are new to this system, you will be asked to set up a profile including username and password
  • Once logged in and viewing the Active Programs screen, select Toronto Ottawa Heart Summit Call for Abstracts
  • Ensure all fields are completed, then submit

Participants may submit either of the following types of abstracts:

Basic Science:
Identify major advances in key areas of cutting-edge research and technology in heart failure, atherosclerosis, stroke, cardiovascular genetics, molecular biology and arrhythmias.

Understand basic processes linking molecular and cellular biology and biochemistry with cardiovascular physiology and pathophysiology.

Clinical Science:
Translate emerging clinical science to clinical practice in patients with cardiovascular disease.

  • Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
  • Atrial Fibrillation, Arrhythmias
  • Preventive Cardiology
  • Population Health & Behavioural Science
  • Heart Failure
  • Personalized Medicine
  • Policy & Guidelines
  • Brain and Heart connections

Note: If you do not know which category your abstract falls within, select 'Undeclared' on the abstract submission form and the Scientific Review Committee will assign a category.

Please follow the guidelines for abstract submission as outlined below:

Abstract Revisions:
After the May 10, 2024 deadline, abstracts may not be revised in any way or resubmitted. Proofread abstracts carefully to avoid errors before submission. If accepted, your abstract will be published as submitted.

Abstract Withdrawal:
Abstracts may be withdrawn by emailing the Conference Coordinator at

Abstract Acceptance:
Abstracts are selected on the basis of scientific merit and are assigned as either oral or poster presentations. Notification of acceptance of abstract will be emailed no later than May 30, 2024.

Using a blind review process, the Scientific Review Committee will review the abstracts using the following criteria:

Abstract Scoring Criteria:

  • Originality
  • Design and Methodology
  • Supporting Data
  • Impact

Click on the BUTTON for more information:

Opt-in/Opt-out of Email Lists

In compliance with anti-spam initiatives: